Assessment of patients' understanding of complex dosages on the medication plan

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00040152

Enrollment

1200

Registered

2026-06-23

Start date

2026-06-23

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evaluation of the comprehensibility of complex dosages on the medication plan

Interventions

Group 1: In this prospective questionnaire-based study, patients in community pharmacies are invited to participate in an anonymous online survey via tablet, which evaluates the comprehensibility of c

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: The survey will include all adult patients who visit a public pharmacy during the survey period and agree to participate. It is irrelevant whether the respondents take medication regularly or not. Only patients whose knowledge of German is sufficient to understand the purpose and scope of this study will be included.

Exclusion criteria

Exclusion criteria: Persons who have not yet reached the age of 18, or who are unable to participate in the survey due to cognitive impairments, acute mental illness, or other relevant factors, are excluded from participation.

Design outcomes

Primary

Measure	Time frame
The primary objective is to conduct a descriptive analysis of the survey regarding the comprehensibility and preferences related to the complex dosing regimens listed on the e-medication plan. In addition, the correct transfer of the complex dosing regimens from the medication plan to medication dispensers will be evaluated. This will be assessed using an online questionnaire and by translating sample dosing regimens from the eMP into pill dispensers.	—

Measure

Time frame

The primary objective is to conduct a descriptive analysis of the survey regarding the comprehensibility and preferences related to the complex dosing regimens listed on the e-medication plan. In addition, the correct transfer of the complex dosing regimens from the medication plan to medication dispensers will be evaluated. This will be assessed using an online questionnaire and by translating sample dosing regimens from the eMP into pill dispensers.

—

Secondary

Measure	Time frame
In addition, hypothesis-based relationships—such, for example, between certain sociodemographic parameters and preferences or the comprehensibility of the complex dosing regimens queried, or the correct transfer of these regimens from the e-medication plan to the medication dispenser—can be explored.	—

Countries

Germany

Contacts

Public ContactHanna Seidling

Universitätsklinikum Heidelberg Universitätsklinikum Heidelberg - Medizinische Klinik - Innere Medizin IX, Abteilung für Klinische Pharmakologie und Pharmakoepidemiologie

Hanna.Seidling@med.uni-heidelberg.de+49 6221 56 38736

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026